课题基金 / 基金详情

GENOMIC ALTERATIONS IN PROSTATE CANCER

GENOMIC ALTERATIONS IN PROSTATE CANCER
前列腺癌的基因组改变
批准号:
6327933
负责人:
SCOTT CRAM
金额:
$1.53万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2001-06-30

项目摘要

项目成果

SCOTT CRAM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Dr. Bova and colleagues at Johns Hopkins have done extensive studies of genomic alterations in prostate cancer and have found a strong tendency for certain chromosomes to be deleted or gained; other chromosome are rarely deleted or gained. They have also studied telomere length in prostate cancer. Their hypothesis is that the tendency toward loss events on specific chromosomes may be related to chromosome-specific telomere length differences. It would be best to study these lengths in specimens isolated directly from patients, however, because metaphase chromosome are difficult to obtain in quantity from these samples, we are using prostate cancer cell lines. Chromosomes #13 and #19 (control) have been sorted and sent to Dr. Griffith for telomere analysis using his very sensitive Southern assay which requires far fewer sorted chromosomes. Significant differences have been reported. Normal human foreskin cells at different stages their life history are als o being analyzed in a similiar manner to establish chromosome to chromosome telomere differences as a function of cell culture progression. Alternative assays are also being evaluated at the present time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR GENETICS OF MALE HYPERTENSION
MOLECULAR GENETICS OF MALE HYPERTENSION
APOPTOSIS VERSUS MALIGNANT PROGRESSION IN BREAST CANCER
CHROMOSOME SORTING FOR MULTISPECTRAL KARYOTYPING
海外基金